Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND) (vol 10, e003032, 2022)

被引:0
|
作者
不详
机构
关键词
D O I
10.1136/bmjdrc-2022-003032corr1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] THE IMPACT OF INSULIN TREATMENT IN COMBINATION WITH ORAL ANTI-DIABETES DRUGS IN REAL-WORLD SETTING IN CHINA: RESULTS FROM SEAS STUDY (SCILIN EFFICACY AND SAFETY OBSERVATIONAL STUDY)
    Mu, Y. M.
    Diao, J. H.
    Xu, F. M.
    Liao, L.
    Xu, C.
    Zhang, Y. M.
    Wang, M. Z.
    Shi, L. P.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S14 - S15
  • [42] Initiating or switching to insulin degludec/insulin aspart in a real-world population of adults with type 2 diabetes in Australia: results from a prospective, non-interventional study
    Fulcher, Gregory R.
    Cohen, Neale D.
    Davies, Katherine
    d'Emden, Michael
    Glastras, Sarah J.
    Mah, Peak M.
    McCallum, Roland W.
    Moses, Robert
    Thong, Ken Y.
    Roberts, Anthony
    INTERNAL MEDICINE JOURNAL, 2024, 54 (10) : 1626 - 1633
  • [43] Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study
    Shaloo Gupta
    Hongwei Wang
    Neil Skolnik
    Liyue Tong
    Ryan M. Liebert
    Lulu K. Lee
    Peter Stella
    Anna Cali
    Ronald Preblick
    Advances in Therapy, 2018, 35 : 43 - 55
  • [44] Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study
    Gupta, Shaloo
    Wang, Hongwei
    Skolnik, Neil
    Tong, Liyue
    Liebert, Ryan M.
    Lee, Lulu K.
    Stella, Peter
    Cali, Anna
    Preblick, Ronald
    ADVANCES IN THERAPY, 2018, 35 (01) : 43 - 55
  • [45] The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in type 2 diabetes patients (TROPHIES): resource use and costs of treatment in clinical practice in France, Germany, and Italy
    Barrett, Annabel
    Boye, Kristina S.
    Garcia-Perez, Luis-Emilio
    Giorgino, Francesco
    Guerci, Bruno
    Fuchtenbusch, Martin
    Yu, Maria
    Sapin, Helene
    Dib, Anne
    Heitmann, Elke
    Federici, Marco Orsini
    Lebrec, Jeremie
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 866 - 879
  • [46] The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES) : Final 24-Month Clinical Characteristics and Treatment Pattern Analyses
    Guerci, Bruno
    Giorgino, Francesco
    Boye, Kristina
    Fuechtenbusch, Martin
    Heitmann, Elke
    Lebrec, Jeremie
    Dib, Anne
    Federici, Marco Orsini
    Yu, Maria
    Garcia-Perez, Luis-Emilio
    DIABETES, 2022, 71
  • [47] Real-World Evaluation of Vildagliptin Plus Metformin in Elderly Patients with Type 2 Diabetes: Results from a One-Year Observational Study in Russia
    Zilov, Alexey
    Emirova, Aida
    DIABETES, 2016, 65 : A595 - A595
  • [48] Quality of Life Assessment in Patients with Type 2 Diabetes: Results from a One-Year Observational Study in Real-World Russian Clinical Settings
    Zilov, Alexey
    Emirova, Aida
    DIABETES, 2016, 65 : A576 - A576
  • [49] Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan: Results from a Retrospective Claims Database Analysis
    Suzuki, Shuichi
    Desai, Urvi
    Strizek, Alena
    Ivanova, Jasmina
    Garcia-Horton, Viviana
    Cai, Zhihong
    Schmerold, Luke
    Liu, Xinyue
    Perez-Nieves, Magaly
    DIABETES THERAPY, 2018, 9 (03) : 1125 - 1141
  • [50] Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan: Results from a Retrospective Claims Database Analysis
    Shuichi Suzuki
    Urvi Desai
    Alena Strizek
    Jasmina Ivanova
    Viviana Garcia-Horton
    Zhihong Cai
    Luke Schmerold
    Xinyue Liu
    Magaly Perez-Nieves
    Diabetes Therapy, 2018, 9 : 1125 - 1141